STOCK TITAN

Verisign insider plans to sell 501 shares via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Verisign, Inc. (VRSN): An insider submitted a Form 144 to report a proposed sale of 501 common shares through Morgan Stanley Smith Barney LLC on 10/07/2025, with an aggregate market value of $135,705.87. The securities were acquired as restricted stock from the issuer on 02/15/2025 and the filer indicates prior small sales of 501-share lots on 07/08/2025, 08/05/2025, 08/12/2025, 09/02/2025, and 09/09/2025, each for roughly $132k–$143k gross proceeds. The filer certifies they are unaware of undisclosed material adverse information and follows Rule 144 disclosure requirements.

Positive

  • Compliance disclosure filed under Rule 144 for a proposed sale of 501 shares
  • Consistent pattern of small-lot sales previously executed between 07/08/2025 and 09/09/2025

Negative

  • None.

Insights

Small, routine insider sales of restricted shares reported; no new disclosures.

The notice records a proposed sale of 501 shares valued at $135,705.87 via Morgan Stanley Smith Barney LLC, consistent with previous small-lot sales listed across 07/08/2025 to 09/09/2025. The securities were acquired as restricted stock from the issuer on 02/15/2025, and the filing follows the procedural requirements of Rule 144.

The primary dependency is routine market execution and compliance with Rule 144 timing/volume limits; the filing does not disclose any new operational or financial information about the issuer. Monitor for any subsequent larger sales or statements that would materially change insider ownership in the near term.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filed for VRSN report?

It reports a proposed sale of 501 common shares of Verisign with an aggregate market value of $135,705.87 scheduled for 10/07/2025.

Who is the broker handling the proposed VRSN sale?

The broker listed is Morgan Stanley Smith Barney LLC located at 1 New York Plaza, 8th Floor, New York, NY.

When were the shares being sold originally acquired?

The shares were acquired as restricted stock from the issuer on 02/15/2025.

Has the filer recently sold other Verisign shares?

Yes. The filing lists prior sales of 501 shares each on 07/08/2025, 08/05/2025, 08/12/2025, 09/02/2025, and 09/09/2025 with gross proceeds around $132k–$143k.

Does the filer assert any undisclosed material information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.